Ampath Chats

Chronic Kidney Disease: Updated Recommendations on Definition and Classification

Ampath Chats
Chronic Kidney Disease: Updated Recommendations on Definition and Classification
Read Document

by Dr. Marita du Plessis

PATHCHAT Edition No. 18
Please contact your local Ampath pathologist for more information.

Introduction

🔹 Definition of Chronic Kidney Disease (CKD):

  • CKD is defined as abnormalities of kidney structure or function lasting longer than three months, with implications for health.

🔹 Updated Classification System (KDIGO 2012):

  • CKD is now classified using the CGA system, which includes:
    • Cause of CKD.
    • Glomerular Filtration Rate (GFR) category.
    • Albuminuria category (marker of kidney damage).
  • The combination of GFR and albuminuria correlates with adverse outcomes.

Criteria for Diagnosing CKD

🔹 One of the following must be present for more than three months:

1. Decreased GFR:

  • A GFR of less than 60 ml/min/1.73m² (Stages G3a–G5) confirms CKD.

2. Markers of Kidney Damage (One or More):

  • Albuminuria:
    • Albumin excretion rate (AER) of 30 mg/day or more.
    • Albumin-to-creatinine ratio (ACR) of 3 mg/mmol or more.
  • Urine sediment abnormalities: Presence of haematuria, red cell casts, white cell casts, or granular casts.
  • Electrolyte and tubular function abnormalities: Indicators of tubular disorders.
  • Histological abnormalities: Detected via kidney biopsy.
  • Structural abnormalities: Found through renal imaging.
  • History of kidney transplantation.

Classification of CKD Using the CGA System

📌 CKD classification now includes cause & albuminuria levels in addition to GFR to improve prognosis accuracy & guide treatment.

1. Assigning the Cause of CKD

CKD causes are classified into two main groups:

  1. Systemic diseases affecting the kidneys (e.g., diabetes, lupus).
  2. Primary kidney diseases without systemic involvement (e.g., glomerulonephritis, polycystic kidney disease).

🔹 Examples of CKD Causes:

Glomerular diseases:

  • Systemic causes: Diabetes, lupus, infections, drugs, amyloidosis.
  • Primary kidney diseases: Glomerulonephritis, focal segmental glomerulosclerosis, membranous nephropathy, minimal change disease.

Tubulointerstitial diseases:

  • Systemic causes: Infections, autoimmune diseases, sarcoidosis, nephrotoxic drugs, urate nephropathy, heavy metal exposure (e.g., lead poisoning).
  • Primary kidney diseases: Chronic pyelonephritis, kidney stone disease, urinary obstruction.

Vascular diseases:

  • Systemic causes: Hypertension, atherosclerosis, cholesterol emboli, vasculitis, thrombotic microangiopathy, systemic sclerosis.
  • Primary kidney diseases: Renal-limited vasculitis, fibromuscular dysplasia.

Cystic and congenital diseases:

  • Systemic causes: Polycystic kidney disease, Alport syndrome, Fabry disease.
  • Primary kidney diseases: Renal dysplasia, medullary cystic disease, podocytopathies.

2. Estimating GFR: Updated Recommendations

Why GFR Calculation Matters:

  • GFR below 60 ml/min/1.73m² is diagnostic for CKD.
  • Estimated GFR (eGFR) should always be reported alongside serum creatinine levels.

Ampath’s GFR Calculation Method:

  • Previously used MDRD equation for GFR estimation.
  • Now transitioning to CKD-EPI equation for better accuracy.

🔹 Advantages of CKD-EPI Equation Over MDRD:

  • More accurate at GFR values above 60 ml/min/1.73m².
  • Less influenced by ethnicity (no race-based correction needed).
  • Improves classification accuracy for younger individuals & women.
  • Better correlation with actual GFR measurements in clinical practice.

Additional GFR Testing Considerations:

  • Cystatin C-based eGFR testing (to be introduced soon at Ampath).
  • Exogenous filtration marker clearance tests (not widely available in South Africa).

3. GFR Categories in CKD

🔹 Stages of CKD Based on GFR:

Stage G1: GFR ≥90 ml/min/1.73m²Normal or high kidney function.
Stage G2: GFR 60–89 ml/min/1.73m²Mildly decreased kidney function.
Stage G3a: GFR 45–59 ml/min/1.73m²Mild to moderate CKD.
Stage G3b: GFR 30–44 ml/min/1.73m²Moderate to severe CKD.
Stage G4: GFR 15–29 ml/min/1.73m²Severe CKD.
Stage G5: GFR <15 ml/min/1.73m²Kidney failure.

📌 Stages G1 & G2 are NOT classified as CKD unless markers of kidney damage are present.

4. Albuminuria as a Marker of Kidney Damage

Why Albuminuria Matters:

  • Best indicator of glomerular disease progression.
  • Higher albumin levels correlate with increased CKD & cardiovascular risks.

Preferred Screening Method:

  • Early morning urine albumin-to-creatinine ratio (ACR) is recommended.
  • Reagent test strips are discouraged due to low sensitivity.

🔹 Albuminuria Categories:

A1 (Normal to Mildly Increased): ACR <3 mg/mmol (AER <30 mg/day).
A2 (Moderately Increased): ACR 3–30 mg/mmol (AER 30–300 mg/day).
A3 (Severely Increased): ACR >30 mg/mmol (AER >300 mg/day).

📌 The term "microalbuminuria" has been replaced with "moderately increased albuminuria" (A2).

5. CKD Prognosis Based on GFR & Albuminuria

📌 The risk of CKD complications increases with lower GFR and higher albuminuria levels.

Risk Factors for Poor Prognosis:

  • GFR decline (especially <30 ml/min/1.73m²).
  • Persistent albuminuria (A2 or A3 category).
  • Diabetes, hypertension, cardiovascular disease.

Low Risk: GFR ≥60 ml/min/1.73m² + normal albumin levels.
Moderate Risk: GFR 45–59 ml/min/1.73m² + moderately increased albuminuria.
High Risk: GFR 30–44 ml/min/1.73m² + severely increased albuminuria.
Very High Risk: GFR <30 ml/min/1.73m² + severe albuminuriaKidney failure risk.

This version is fully formatted for Webflow’s Rich Text Editor with structured lists, bullet points, and clear headings.
All tables have been converted to clear, readable lists as requested.